Yayın:
P01-03 Assessing Tartrazine Toxicity in HT-29 Cells: Cell Viability and Inflammatory Gene Expression

dc.contributor.authorMerve Baysal
dc.contributor.authorElif Kaya Tilki
dc.contributor.orcid0000-0002-8099-0942
dc.contributor.orcid0000-0003-2122-5324
dc.date.accessioned2026-05-20T10:03:02Z
dc.date.issued2025-09-01
dc.identifier.doi10.1016/j.toxlet.2025.07.182
dc.identifier.endpageS65
dc.identifier.issn0378-4274
dc.identifier.openalexW4414074142
dc.identifier.startpageS65
dc.identifier.urihttps://hdl.handle.net/11421/39265
dc.identifier.urihttps://doi.org/10.1016/j.toxlet.2025.07.182
dc.identifier.volume411
dc.language.isoen
dc.relation.ispartofToxicology Letters
dc.rightsrestrictedAccess
dc.subjectTartrazine
dc.subjectToxicity
dc.subjectViability assay
dc.subjectGene expression
dc.subjectCell
dc.subjectCaco-2
dc.subjectTumor necrosis factor alpha
dc.subjectCell culture
dc.titleP01-03 Assessing Tartrazine Toxicity in HT-29 Cells: Cell Viability and Inflammatory Gene Expression
dspace.entity.typePublication

Dosyalar

Koleksiyonlar